Rosetta Genomics Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Table Of Content
- Licence Rights
- Section Purchase
Rosetta Genomics Ltd.-Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Marketline's Rosetta Genomics Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Rosetta Genomics Ltd. since January2007.
Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
This report includes Rosetta Genomics Ltd. 's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Rosetta Genomics Ltd. . These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
- Provides intelligence on Rosetta Genomics Ltd. 's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Rosetta Genomics Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Rosetta Genomics Ltd. 's financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Rosetta Genomics Ltd. 's growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.
Table Of Content
Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions-Overview 7
Mergers and Acquisitions-Deal reports 8
Partnership-Deal reports 14
CAPITAL RAISING 91
Capital Raising-Overview 91
Capital Raising-Deal reports 92
Divestments-Deal reports 121
PRIVATE EQUITY & OWNERSHIP 123
Private Equity and Ownership-Deal reports 123
Contact Us 125
About MarketLine Financial Deals Database 125
Deal Definition and Methodology 127
About MarketLine 134
List Of Figure
List of Figures
Figure 1: Rosetta Genomics Ltd. M&A volume and value trend (2014-YTD2018)
Figure 2: Rosetta Genomics Ltd. M&A activity by geography (2014-YTD2018)
Figure 3: Rosetta Genomics Ltd. partnership volume and value trend (2014-YTD2018)
Figure 4: Rosetta Genomics Ltd. partnership trend by key deal type (2014-YTD2018)
Figure 5: Rosetta Genomics Ltd. capital raising volume and value trend (2014-YTD2018)
Figure 6: Rosetta Genomics Ltd. capital raising by deal type (2014-YTD2018)
List Of Table
List of Tables
Table 1: Rosetta Genomics Ltd. M&A volume and value trend (2014-YTD2018)
Table 2: Rosetta Genomic
Single User License:
Report can be used by individual purchaser only
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company